Friday, February 13, 2026

Latest

Microsoft: Earnings Estimates For Q1 2022

Microsoft (NASDAQ: MSFT) will be reporting its first quarter financial results on the 26th after the markets close. Analysts have a consensus $339.26 12-month price target on the company, via a total of 41 analysts, with 17 analysts having strong buy ratings. 22 analysts meanwhile have buy ratings, and 2 analysts have hold ratings on the company. The street high sits at a $384 price target, and the lowest target sits at $281.78.

25 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 25 analysts is $44.97 billion; this number has been revised upwards from $41.90 billion at the start of April. The highest revenue estimate is $44.77 billion, while the lowest is $43.66 billion.

Onto EBITDA estimates, there are currently 4 analysts who have first-quarter EBITDA estimates. The mean is currently $22.28 billion, with this number having been revised upwards from $20.35 billion at the start of April. The street high estimate currently sits at $22.76 billion in EBITDA and the lowest is $21.56 billion.

Analysts estimate that quarterly earnings per share will come in at $2.07, with this number being revised upwards from $1.90 at the start of April. Street high is $2.17 and the lowest estimate is $2.03 per share for the quarter.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Back to the Cariboo: Gold Rush History Meets Modern Discovery | Golden Caribou

Gold Prices Are High, Experience Matters | Rob McLeod

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

Mind Medicine: Canaccord Genuity Initiates Coverage With C$1.75 Price Target

Yesterday, Canaccord initiated coverage on Mind Medicine (NEO: MMED) with a Speculative Buy rating and...

Wednesday, September 16, 2020, 04:15:00 PM

Goodfood: Canaccord Raises Price Target To $11.50 Ahead Of Earnings

This morning, Canaccord Genuity raised their 12-month price target to C$11.50 from C$9.50 and reiterated...

Tuesday, October 27, 2020, 04:26:00 PM

Cronos Group: Analysts Expect Another Quarterly Loss For Q2

Cronos Group (TSX: CRON) announced that they will be reporting their second quarter financials before...

Wednesday, August 4, 2021, 03:50:00 PM

Tilray Sees Haywood Slash Price Target To $12.50

On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the...

Sunday, October 10, 2021, 04:49:00 PM

Google Unveils New Chatbot to Rival OpenAI’s ChatGPT

In an effort to compete with OpenAI’s widely popular chatbot, Alphabet’s (NASDAQ: GOOGL) Google is...

Tuesday, February 7, 2023, 06:04:00 AM